Clinical Trials
3 trialsNCT02053636 2024-07-25
FINESSE
Servier
Phase 2 Completed
NCT03992131 2024-01-16
A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Participants With a Solid Tumor (SEASTAR)
pharmaand GmbH
Phase 1/2 Terminated
NCT02202746 2020-06-23
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
Clovis Oncology, Inc.
Phase 2 Terminated